A c c e p t e d M a n u s c r i p t 4 endogenous ones, by the AhR. Those ligands remain to be identified. Moreover, the 1 AhR signaling pathway in these invertebrates is highly conserved (i.e. 2 heterodimerization with ARNT orthologs and binding to XREs). 3 Studies using invertebrates and vertebrates in which the AhR has been 4 knocked out have unraveled some functions of the AhR that are not related to 5 xenobiotic metabolism. In the worm, AhR1{3. AU: I have changed AHR-1 to AhR1 to 6 tie in with style used below for the vertebrates. If AHR-1 is specific to the worm 7 please check this section and change back but also consider use of AhR1 and 2 8 below} is expressed in several neurons and blast cells during embryonic and larval 9 development. Worms that lack AhR1 display several neurological defects (e.g. social 10 feeding behavior), which affect neuronal differentiation, axon guidance and cell 11 migration. These functions appear to result from the indirect transcriptional control 12 that AhR1 exerts on a G-coupled{4. AU: Is this ok or should it be G-protein-coupled?} 13 neuropeptide receptor and on some members of the soluble guanylate cyclase family 14 [5]. In the fly, SPINELESS is expressed in several tissues during embryonic and 15 pupal development but it mainly regulates the leg development, the morphology of 16 the peripheral nervous system and the differentiation of photoreceptors that are 17 required for color vision [6] . 18 These observations demonstrate that AhR orthologs play a part in the 19 development of invertebrates. However, the mechanism by which AhR is activated in 20 these organisms remains elusive, particularly as to whether or how a ligand might be 21 involved. At present, there is a limited amount of evidence available to demonstrate 22 that the functions the receptor exerts in invertebrates, such as promoting neuronal 23 development, are conserved in vertebrates. One might speculate that, during 24 Page 5 of 30 A c c e p t e d M a n u s c r i p t 5 evolution, mutations in the PAS domains led to the acquisition of new functions (e.g. 1 xenobiotic metabolism) and to a broader tissue distribution of the receptor.
2 In vertebrates, the AhR genes are divided into two distinct clade lineages, 3 AhR1 and AhR2. During vertebrate evolution, these two clades underwent tandem 4 gene duplication events. For example, in fish several AhR isoforms are present (i.e. 5 2-6 per species), whereas mammals express only a single protein. In the zebrafish 6 three forms have been identified [7] . The first form, AhR1a, does not bind exogenous 7 ligands and its function is unknown. By contrast, the biological functions of AhR2 8 appear to be similar to those of the mammalian AhR. Recently, a third form, AhR1b 9 was identified which can also bind exogenous ligands [8] . The three isoforms are 10 expressed differently in tissues. A number of questions remain unanswered. In 11 particular, it is unclear whether AhR1a and AhR1b possess physiologic functions in 12 the brain and in the other organs in which they are expressed and whether some or 13 all of these functions are conserved in mammals.
14
The characterization of AhR orthologs and paralogs provides insights into the 15 ancestral functions of the receptor and suggests that AhRs in mammals have roles in 16 addition to that of regulating the expression of xenobiotic metabolizing enzymes.
17
Indeed, three laboratories have observed phenotypic abnormalities in mice lacking 18 the AhR [9]. These three mouse models share many phenotypic similarities such as 19 resistance to dioxin toxicity, infertility, liver and cardiovascular abnormalities, and 20 delayed growth. These models, however, also display significant differences, for 21 example sensitivity to infection [10] .
22
All these recent studies suggest that the AhR can be active in the absence of 23 exogenous ligands. The discovery of endogenous ligands is, thus, a crucial aspect 24 for understanding the biology of the AhR better. Heart and lung extracts [11] have M a n u s c r i p t 6 been shown to contain AhR activators and several molecules have been identified as 1 putative ligands: arachidonic acid and leukotrienes, heme metabolites and UV 2 photoproducts of tryptophan [12] . Among the most significant studies, 6-3 formylindolo[3,2-b]carbazole (FICZ), a tryptophan derivative with a high affinity for the 4 AhR, has been identified as a ligand and activator of CYP1A1 transcription [13] . FICZ 5 action on cells is transient as a result of metabolism by CYP1. Another tryptophan 6 metabolite, kynurenine has been shown to bind to the AhR, and was recently 7 implicated in the development of brain tumors [14] . It is noteworthy that the AhR, as 8 well as several of its ligands, has been associated with the promotion or the 9 prevention of atherosclerosis [15, 16] . The presence of AhR-activating compounds, 10 such as oxidized low-density lipoprotein (LDL), has also been demonstrated in 11 sheared human and bovine sera [17] .
12
In parallel to the identification of putative endogenous ligands, new AhR 13 xenobiotic activators that are substantially different from polycyclic aromatic 14 hydrocarbons have been identified and characterized [12, 18] . They have been 15 described as AhR antagonists because they usually antagonize CYP induction.
16
However, recent studies have demonstrated that these molecules activate the AhR, 17 differentially, through alternative transcriptional responses.
18
Alternative AhR transcriptional responses (Figure 1 ) 19 The XRE track 20 The first relevant study in this area concerned the pro-apoptotic protein Bax, which is promoter led to the identification of a TCDD-unresponsive XRE, which was defined 1 as an unusual responsive element (Table 1) . We also identified an unusual AhR 2 target, paraoxonase 1 (PON1), which is a high-density lipoprotein-associated 3 enzyme, involved in the elimination of organophosphorous xenobiotics and toxic 4 endogenous compounds. Several AhR ligands (e.g. polyphenolic compounds such 5 as quercetin or resveratrol but also 3-methylcholanthrene) have been shown to 6 induce PON1 in a human hepatoma cell line in an AhR-dependant manner [20] . 7 However, TCDD was a poor inducer. Interestingly, promoter analysis has led to the 8 identification of a crucial sequence in the proximal part of the promoter, which is 9 slightly different from the consensus XRE (Table 1) . Finally, another alternative 10 sequence similar to the one identified in the promoter of PON1 (named AhR-RE type 11 III; Table 1 ) was recently found in the tyrosine hydroxylase gene promoter [21] . Please confirm text here} interacts with ERα and this complex induces transcription 1 of ERα target genes [28] . In conclusion, AhR has a dual role depending on the 2 estrogen concentration.
3 Despite a large number of studies that have been conducted on this crosstalk, many 4 questions remain unanswered. Indeed, it is tempting to hypothesize that diverse AhR 5 ligands will act differently on the ERα pathway. Moreover, to date, the binding of the 6 AhR to iXREs has not been investigated in the presence of these new AhR ligands. (Table 1) , localized in the 1 promoter of the interleukin 8 gene [33, 34] .
2
Immunosupressive effects of TCDD have also been described. A number of 3 studies have shown that dioxin and the AhR can suppress NF-κB activity in immune 4 murine cell lines [35, 36] . Ruby and colleagues [35] {7. AU: Is this the correct citation 5 that I have inserted here?} showed that this inhibition was caused by the formation of 6 a RelA-AhR dimer, without DNA binding.
7
AhR ligands can be considered as potential modulators of NF-κB. In this 8 respect, resveratrol and other stilbene derivatives also display anti-inflammatory 9 properties [37] . Although several mechanisms probably play a part, it is conceivable 10 that the AhR could be involved. AhR does not affect CYP1A1 transcription, suggesting that it could activate an 23 unknown alternative response. Other studies have shown that PKC activity is 24 required for ligand-dependent AhR signaling [38] . PKC-dependant phosphorylation of M a n u s c r i p t 11 the AhR and/or ARNT seems to be required but it is not sufficient for the 1 transcriptional activity of this heterodimer. One can suspect that, as for nuclear 2 receptors, this phosphorylation could also impact co-activator recruitment. 3 Calcium has also been shown to regulate the AhR pathway. Increased 4 intracellular calcium in cells exposed to TCDD or PAH has been reported but Ca 2+ 5 also modulates the AhR response because it has been shown to be required for the This decrease is caused by a stimulated, selective degradation by the proteasome 23 and constitutes a simple feedback mechanism at the protein level. Another crucial 24 feedback mechanism involving the AhR repressor (AHRR) was discovered several characteristics for a compound named GNF351, defined as a 'pure antagonist', which 10 displays a high affinity for the AhR and an anti-inflammatory potential [53] .
11
In addition to its modulation of inflammation, the AhR has also been recently Interestingly, those recruitments (including the AhR) display a sinusoidal variation 9 after β-NF treatment suggesting that this process is highly dynamic. However, only β-10 NF triggered the binding of RNA polymerase II [64] . Finally, several studies have 11 established that AhR ligands can also trigger AhR-independent processes at the cell 12 membrane. These effects need to be characterized better to determine the 13 responses regulated by the AhR. Several approaches can be proposed to solve 14 these problems. For example, AhR knockout models will be suitable tools to decipher 15 the effects of alternative ligands such as resveratrol and large-scale, high-throughput 16 studies will be relevant in this experimental picture. Moreover, development of 17 reporter genes sensitive to each pathway modulated by the AhR as well as the 18 elucidation of its 3D structure will be breakthroughs in the field. 19 The AhR has been, directly or indirectly, linked to pathophysiological 20 processes including atherosclerosis, inflammation, immunomodulation and cancer. 
